icotec is honored to be the first and only company in the United States with FDA 510(k) clearance for stabilizing the spine in de novo spinal infections, including discitis, osteomyelitis, pyogenic ...
ALTSTÄTTEN, Switzerland and BOSTON, Nov. 13, 2025 /PRNewswire/ -- icotec, the pioneer of implantable devices made from BlackArmor ® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug ...
icotec AG, a Swiss company, today announced that its latest line of interbody cages, designed to optimize bony integration and post-operative visualization has received U.S. Food and Drug ...
ALTSTAETTEN, Switzerland and EAST HARTFORD, Conn., Feb. 6, 2024 /PRNewswire/ -- icotec ag, the leading company in the field of innovative spinal tumor implants is pleased to announce the appointment ...
ALTSTAETTEN, Switzerland, July 8, 2019 /PRNewswire/ -- icotec AG, a Swiss company, today announced the VADER ® one pedicle screw system was granted U.S. Food and Drug Administration (FDA) 510(k) ...
ALTSTAETTEN, Switzerland, June 18, 2020 /PRNewswire/ -- icotec ag announces that the KONG®-TL and the KONG®-C vertebral body replacement systems with the unique Titaniumcoating (Ti-iT®) receive FDA ...
ALTSTAETTEN, Switzerland and EAST HARTFORD, Conn., Jan. 24, 2024 /PRNewswire/ -- icotec ag, the leading company in the field of innovative spinal tumor implants is pleased to announce a significant ...
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results